Atlas Trials

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Clinical trial NCT01995695 · COMPLETED

Trial details

NCT number
NCT01995695
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza A Virus, H7N9 Subtype
Start date
2013-10-01
Primary completion
2016-01-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.